Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115626893B reveals a cost-effective synthesis route for 2-hydroxy-5-hydroxymethylpyridine, offering significant supply chain and purity advantages for global manufacturers.
Novel patent CN117865832A offers high purity synthesis for GLP-1 intermediates. Reduces impurities and simplifies scale-up for reliable pharmaceutical intermediate supply chains.
Patent CN102942542A details a cost-effective Ru-catalyzed route for 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid, offering significant supply chain advantages.
Novel feruloyl esterase method reduces solvent use. Efficient aqueous phase synthesis for pharmaceutical intermediates. Supply chain reliability and cost optimization.
Patent CN107805229B details a novel metal-ion catalyzed route for levulinic acid dimerization, offering high-purity intermediates and cost reduction in fine chemical manufacturing.
Novel synthesis route for doxylamine succinate intermediate. High yield, safe process, reliable supply chain for global pharmaceutical manufacturing partners.
Patent CN116986986A reveals a novel synthesis route for 3-oxo-1-cyclobutanecarboxylic acid intermediates, offering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturing.
Novel synthesis method improves yield and purity for pharmaceutical intermediates. Reduces cost and enhances supply chain reliability for global buyers.
Patent CN101914595A reveals enzymatic route for ferulic acid sugar esters offering green manufacturing advantages and supply chain stability for global pharmaceutical intermediates procurement.
Patent CN118272464A reveals enzymatic synthesis of alpha-hydroxystearic acid. Offers green, high-yield production for reliable ceramide precursor supply chains.
Patent CN102030648B details a novel asymmetric dihydroxylation route for high-purity chiral intermediates, offering scalable manufacturing and cost efficiency for cardiovascular drug production.
Novel Ni-catalyzed route for chiral nafoxidine-3-carboxylic acid. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115215835A reveals a high-yield two-step Negishi coupling route for isoindoline intermediates, offering significant cost and safety advantages for API manufacturing.
Patent CN107602658A reveals a novel synthesis for high-purity ursolic acid derivatives with significant antitumor activity and simplified commercial manufacturing processes.
Patent CN101519407B details a catalyst-free dehydration method for cyclic acid anhydrides, offering >99% yield and significant cost reduction in API manufacturing.
Patent CN111410604B details iridium-catalyzed asymmetric hydrogenation of enenoic acids, offering a direct route to chiral intermediates with high enantioselectivity and reduced processing steps.
Patent CN103613602B reveals novel gambogic acid derivatives with enhanced solubility. Discover supply chain advantages and scalable synthesis for pharmaceutical intermediates.
Discover the patented CN102134252B process for synthesizing >99% pure cefuroxime acid. Learn how ternary solvent extraction reduces lactone impurities and ensures supply chain stability.
Patent CN101870704A reveals a room-temperature purification method for cefotetan acid, drastically reducing isomer content and enhancing manufacturing efficiency for pharmaceutical intermediates.
Patent CN113234055B reveals a novel copper-polyselenide catalytic system for lactide synthesis, offering high optical purity and recyclable catalysts for cost-effective polylactic acid production.